Patient-reported and physician-estimated adherence to HAART
暂无分享,去创建一个
Albert W. Wu | Rita Murri | A. Wu | A. Antinori | V. Tozzi | P. Noto | A. Monforte | M. Trotta | R. Murri | A. Ammassari | A. Luca | Valerio Tozzi | Mauro Zaccarelli | Maria Paola Trotta | Andrea Antinori | Adriana Ammassari | Andrea Luca | Sara Melzi | Cristina Minardi | Patrizia Rellecati | Paola Santopadre | Fabrizio Soscia | Antonio Scasso | Maria Ciardi | Gian Carlo Orofino | Pasquale Noto | Antonella d’Arminio Monforte | the AdICoNA Study Group | G. Orofino | M. Ciardi | M. Zaccarelli | P. Santopadre | S. Melzi | C. Minardi | F. Soscia | A. Scasso | Patrizia Rellecati
[1] D Johnson,et al. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group. , 1999, AIDS.
[2] N. Tubiana-Rufi,et al. Discordance between physician and adolescent assessments of adherence to treatment: influence of HbA1c level. The PEDIAB Collaborative Group. , 1999, Diabetes Care.
[3] A. Loundou,et al. Physician Recognition of Active Injection Drug Use In HIV-Infected Patients Is Lower Than Validity of Patient's Self-Reported Drug Use , 2001 .
[4] R. Haynes,et al. Is this patient taking the treatment as prescribed , 1993 .
[5] M. Moroni,et al. Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients , 2000, AIDS.
[6] Barbara Gandek,et al. Patient and Visit Characteristics Related to Physicians' Participatory Decision-Making Style: Results from the Medical Outcomes Study , 1995, Medical care.
[7] William A. Knaus,et al. A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators. , 1995, JAMA.
[8] A. Antinori,et al. Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA) , 2002, AIDS.
[9] D. Brody. Physician recognition of behavioral, psychological, and social aspects of medical care. , 1980, Archives of internal medicine.
[10] W. Gregory,et al. Who should measure quality of life, the doctor or the patient? , 1988, British Journal of Cancer.
[11] J. Fleishman,et al. Effect of Case Management on Unmet Needs and Utilization of Medical Care and Medications among HIV-Infected Persons , 2001, Annals of Internal Medicine.
[12] A. Wu,et al. Patient-reported nonadherence to HAART is related to protease inhibitor levels. , 2000 .
[13] N. Aaronson,et al. The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: A review , 1992 .
[14] Christianna S. Williams,et al. Goals for the care of frail older adults: do caregivers and clinicians agree? , 2001, The American journal of medicine.
[15] H. Rubin,et al. A Health Status Questionnaire Using 30 Items From The Medical Outcomes Study: Preliminary Validation in Persons With Early HIV Infection , 1991, Medical care.
[16] J. Moatti,et al. The Dynamic of Adherence to Highly Active Antiretroviral Therapy: Results From the French National APROCO Cohort , 2001, Journal of acquired immune deficiency syndromes.
[17] D. Richman,et al. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. , 2000 .
[18] R. Califf,et al. Factors associated with change in resuscitation preference of seriously ill patients. The SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. , 1996, Archives of internal medicine.
[19] D. Patrick,et al. The quality of patient-doctor communication about end-of-life care: a study of patients with advanced AIDS and their primary care clinicians. , 1999, AIDS.
[20] S. van der Linden,et al. Comparison between self-report measures and clinical observations of functional disability in ankylosing spondylitis, rheumatoid arthritis and fibromyalgia. , 1994, Journal of Rheumatology.
[21] V. Calvez,et al. Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team). , 2000, JAMA.
[22] A. Fontaine,et al. Physicians' recognition of the symptoms experienced by HIV patients: how reliable? , 1999, Journal of pain and symptom management.
[23] J. Moatti,et al. Injecting drug users' adherence to HIV antiretroviral treatments: Physicians' beliefs , 2000, AIDS care.
[24] R. Epstein,et al. Awkward Moments in Patient-Physician Communication about HIV Risk , 1998, Annals of Internal Medicine.
[25] Marilyn M. Wagener,et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection (vol 133, pg 21, 2000) , 2002 .
[26] E. Kohli,et al. Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: relationship to virologic response. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[27] P. Viens,et al. Discordance between physicians' estimations and breast cancer patients' self-assessment of side-effects of chemotherapy: an issue for quality of care. , 1997, British Journal of Cancer.
[28] E. H. Kaplan,et al. Public Health Consequences of Screening Patients for Adherence to Highly Active Antiretroviral Therapy , 2001, Journal of acquired immune deficiency syndromes.
[29] F. Brun-Vézinet,et al. Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen , 2002, AIDS.
[30] F. Hecht,et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population , 2000, AIDS.
[31] W. Söllner,et al. How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling? , 2001, British Journal of Cancer.
[32] R B Haynes,et al. Predicting compliance with a regimen of digoxin therapy in family practice. , 1980, Canadian Medical Association journal.
[33] Susan Swindells,et al. Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection , 2000, Annals of Internal Medicine.
[34] A. Wu,et al. Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms: a comparison with self-reported symptoms. Outcomes Committee of the AIDS Clinical Trials Group. , 1999, Journal of acquired immune deficiency syndromes.
[35] A. Wu,et al. Self‐Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV Infection , 2001, Journal of acquired immune deficiency syndromes.
[36] M. Wainberg,et al. Public health implications of antiretroviral therapy and HIV drug resistance. , 1998, JAMA.
[37] D. Nicolau,et al. Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[38] F. Hecht,et al. Provider Assessment of Adherence to HIV Antiretroviral Therapy , 2001, Journal of acquired immune deficiency syndromes.